36F79721D0166 - BPA FOR ORLADEYO AND RAPIVAB
Federal Contract Award Search » BPA Award - Pharmaceuticals and Drugs
This BPA contract for Pharmaceuticals > Pharmaceutical Products was awarded in FY2026 on Jun 2, 2026 to BIOCRYST PHARMACEUTICALS, INC. by National Acquisition Center. There have been no obligations to date with a ceiling value of $93M, showing a ~0% burn rate so far on the contract. The contract was not competed under any preference program with 1 offer received.
BIOCRYST PHARMACEUTICALS, INC. is a contractor located in NC, doing primarily Pharmaceuticals > Pharmaceutical Products work for Veterans Affairs. The company receives $16.1M annually in federal awards (as of FY2020). Also, they have shown success winning No/Limited Bias contracts concentrated mainly on a singular customer focused portfolio.
Blanket Purchase Agreements or BPAs establish a method for the Government to satisfy a repetitive need for goods and services. When a government-wide need exists for specific products or services, a BPA allows the Government to establish a single contract to satisfy those needs. Creating a single source for common needs enables the Government to use buying power to drive down prices and avoid the higher costs associated with hundreds or thousands of customers purchasing independently.
- Contract Number
- 36F79721D0166
- Contractor
- BIOCRYST PHARMACEUTICALS, INC.
- Obligations to Date
- $0.00
- Ceiling Value
- $93M
- Award Date
- 06/02/2026
- Contract Type
- BPA
- Contract Vehicle
- Pharmaceuticals and Drugs
- Buying Agency/Office
- Veterans Affairs»VA Office of Acquisition, Logistics and Construction»Office of Procurement, Acquisition and Logistics»National Acquisition Center
Win More Federal Business
Imagine a world where every report, every insight is tailored specifically to you. Our entire platform is configured around your past performance so that everything is relevant.
All the Right Tools
Business Development & Pipeline Management
We start with the largest federal opportunity database, including forecasts and re-competes, and add layer a suite of pipeline management tools.
Personalized Markets
Our market-centric platform adds context to every pursuit. Every opportunity, every report, tailored specifically to you.
Award Research & Market Intelligence
Find gaps in the market, identify key competitors and teaming partners, evaluate performance, and analyze pathways to new business.
Start Your Free Account Today
That's right. It's free to get started with Federal Compass
Gain Full Access to This Report and...
Contract Opportunities
Pipeline Management
Award Research
Funding Analysis
Partner Identification
Industry and Market Intel
Agency Spending Trends
Competitive Insights
Enjoy instant access to the Federal Compass platform
BPA Call History
| BPA Call No. | Contractor | Obligations | Effective Date |
|---|---|---|---|
| 36C26022F0188 | BIOCRYST PHARMACEUTICALS, INC. | $85.1k | 03/08/2022 |
| 36C26022F0215 | BIOCRYST PHARMACEUTICALS, INC. | $113.4k | 05/20/2022 |
| 36C26023F0144 | BIOCRYST PHARMACEUTICALS, INC. | $56.7k | 01/20/2023 |
| 36C26124N0446 | BIOCRYST PHARMACEUTICALS, INC. | $0.00 | 02/16/2024 |
| 36C26024F0240 | BIOCRYST PHARMACEUTICALS, INC. | $29.6k | 02/20/2024 |
| 36C26024F0258 | BIOCRYST PHARMACEUTICALS, INC. | $201.7k | 03/01/2024 |
| 36C26024F0270 | BIOCRYST PHARMACEUTICALS, INC. | $357.2k | 03/12/2024 |
| 36C26024F0625 | BIOCRYST PHARMACEUTICALS, INC. | $379.3k | 09/09/2024 |
| 75A50324F80012 | BIOCRYST PHARMACEUTICALS, INC. | $13.9M | 09/23/2024 |
| 36C26025F0024 | BIOCRYST PHARMACEUTICALS, INC. | $379.9k | 10/01/2024 |
| 36C26025F0070 | BIOCRYST PHARMACEUTICALS, INC. | $243k | 11/04/2024 |
| 36C26025F0296 | BIOCRYST PHARMACEUTICALS, INC. | $29.4k | 06/18/2025 |
| 36C26026F0006 | BIOCRYST PHARMACEUTICALS, INC. | $360k | 10/01/2025 |
| 36C26026F0294 | BIOCRYST PHARMACEUTICALS, INC. | $151.5k | 05/19/2026 |
| 36C24926F0152 | BIOCRYST PHARMACEUTICALS, INC. | $30.3k | 05/21/2026 |
